TNFSF8 is a member of the cytokines CD30 ligand/tumor necrosis factor superfamily and may serve as predictive biomarkers for pancreatic cancer patients' response to gemcitabine and erlotinib (Torres et al., 2014). The gene discussed is TNFRSF8; the disease is pancreatic neoplasm.